GlassScriptPhysician profile
Tara Connor
NPI 1417998915
$1,247.54
in general payments reported to CMS, 2019-2025
18 companies · $19.80 in 2025
The $19.80 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $727 · 2020: $274 · 2021: $111 · 2022: $97.69 · 2024: $18.76 · 2025: $19.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $326.89 | 2019-2022 | |
| Amgen INC. | $196.28 | 2019-2025 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $106.14 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $89.02 | 2019-2020 | |
| Novo Nordisk INC | $69.21 | 2019-2020 | |
| Allergan, INC. | $59.19 | 2019-2020 | |
| Pfizer INC. | $52.98 | 2019-2020 | |
| Lilly USA, LLC | $50.35 | 2019-2020 | |
| Amarin Pharma, INC. | $49.68 | 2019 | |
| Astellas Pharma US INC | $44.30 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $39.68 | 2019-2020 | |
| Eisai INC. | $37.50 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $37.08 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $22.66 | 2019 | |
| Sumitomo Pharma America, INC. | $18.76 | 2024 | Gemtesa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.69 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.10 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Connor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.